FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161853348> ?p ?o ?g. }

• W2161853348 endingPage "904" @default.
• W2161853348 startingPage "895" @default.
• W2161853348 abstract "To describe India's National Antimalarial Drug Resistance Monitoring System, measure the efficacy of first-line malaria treatments, and determine risk factors for treatment failure.In 2009-2010, prospective studies with 28 days of follow-up were conducted at 25 sentinel sites. Patients infected with Plasmodium falciparum were given artesunate plus sulfadoxine-pyrimethamine (AS+SP); those infected with P. vivax were given chloroquine. Polymerase chain reaction was used to distinguish post-treatment reinfection from treatment failure. Isolates of P. falciparum were checked for dhfr and dhps mutations.Overall, 1664 patients were enrolled. Kaplan-Meier survival analysis showed an efficacy of 98.8% for AS+SP. Most patients with P. falciparum parasitaemia cleared their parasitaemias within 24 hours of treatment initiation, but six, including four with treatment failure, remained parasitaemic after 72 hours. Double mutants in dhfr were found in 68.4% of the genotyped isolates. Triple or quadruple mutants in dhfr and mutations in dhps were rare. A daily dose of artesunate of < 3 mg per kg of body weight, age of less than 5 years, and fever at enrolment were associated with an increased risk of treatment failure. Chloroquine remained 100% efficacious and generally cleared P. vivax parasitaemias within 48 hours. Vomiting (seen in 47 patients) was the most common adverse event.India's National Antimalarial Drug Resistance Monitoring System provides wide coverage. The first-line antimalarials used in the country remain safe and efficacious. The treatment of malaria in young children and the relative benefits of age- and weight-based dosing need further exploration." @default.
• W2161853348 created "2016-06-24" @default.
• W2161853348 creator A5018231474 @default.
• W2161853348 creator A5023145210 @default.
• W2161853348 creator A5034866415 @default.
• W2161853348 creator A5044082392 @default.
• W2161853348 creator A5047259529 @default.
• W2161853348 creator A5051972045 @default.
• W2161853348 creator A5063868346 @default.
• W2161853348 creator A5064354766 @default.
• W2161853348 creator A5064695202 @default.
• W2161853348 creator A5067857554 @default.
• W2161853348 creator A5070462000 @default.
• W2161853348 creator A5071993812 @default.
• W2161853348 creator A5075900350 @default.
• W2161853348 creator A5078099901 @default.
• W2161853348 creator A5081893010 @default.
• W2161853348 creator A5090067871 @default.
• W2161853348 date "2012-10-31" @default.
• W2161853348 modified "2023-09-23" @default.
• W2161853348 title "Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009–2010" @default.
• W2161853348 cites W1574696683 @default.
• W2161853348 cites W1592864042 @default.
• W2161853348 cites W2008754328 @default.
• W2161853348 cites W2013267325 @default.
• W2161853348 cites W2040095486 @default.
• W2161853348 cites W2047650591 @default.
• W2161853348 cites W2051080253 @default.
• W2161853348 cites W2087154840 @default.
• W2161853348 cites W2135837557 @default.
• W2161853348 cites W2155680390 @default.
• W2161853348 cites W2158149195 @default.
• W2161853348 cites W2161311583 @default.
• W2161853348 cites W2161510631 @default.
• W2161853348 cites W2172243766 @default.
• W2161853348 cites W2335916635 @default.
• W2161853348 doi "https://doi.org/10.2471/blt.12.109124" @default.
• W2161853348 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3524963" @default.
• W2161853348 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23284195" @default.
• W2161853348 hasPublicationYear "2012" @default.
• W2161853348 type Work @default.
• W2161853348 sameAs 2161853348 @default.
• W2161853348 citedByCount "32" @default.
• W2161853348 countsByYear W21618533482013 @default.
• W2161853348 countsByYear W21618533482014 @default.
• W2161853348 countsByYear W21618533482015 @default.
• W2161853348 countsByYear W21618533482016 @default.
• W2161853348 countsByYear W21618533482017 @default.
• W2161853348 countsByYear W21618533482018 @default.
• W2161853348 countsByYear W21618533482019 @default.
• W2161853348 countsByYear W21618533482020 @default.
• W2161853348 countsByYear W21618533482021 @default.
• W2161853348 countsByYear W21618533482022 @default.
• W2161853348 countsByYear W21618533482023 @default.
• W2161853348 crossrefType "journal-article" @default.
• W2161853348 hasAuthorship W2161853348A5018231474 @default.
• W2161853348 hasAuthorship W2161853348A5023145210 @default.
• W2161853348 hasAuthorship W2161853348A5034866415 @default.
• W2161853348 hasAuthorship W2161853348A5044082392 @default.
• W2161853348 hasAuthorship W2161853348A5047259529 @default.
• W2161853348 hasAuthorship W2161853348A5051972045 @default.
• W2161853348 hasAuthorship W2161853348A5063868346 @default.
• W2161853348 hasAuthorship W2161853348A5064354766 @default.
• W2161853348 hasAuthorship W2161853348A5064695202 @default.
• W2161853348 hasAuthorship W2161853348A5067857554 @default.
• W2161853348 hasAuthorship W2161853348A5070462000 @default.
• W2161853348 hasAuthorship W2161853348A5071993812 @default.
• W2161853348 hasAuthorship W2161853348A5075900350 @default.
• W2161853348 hasAuthorship W2161853348A5078099901 @default.
• W2161853348 hasAuthorship W2161853348A5081893010 @default.
• W2161853348 hasAuthorship W2161853348A5090067871 @default.
• W2161853348 hasBestOaLocation W21618533481 @default.
• W2161853348 hasConcept C114851261 @default.
• W2161853348 hasConcept C126322002 @default.
• W2161853348 hasConcept C203014093 @default.
• W2161853348 hasConcept C2776120307 @default.
• W2161853348 hasConcept C2776793103 @default.
• W2161853348 hasConcept C2777035104 @default.
• W2161853348 hasConcept C2777425658 @default.
• W2161853348 hasConcept C2777616469 @default.
• W2161853348 hasConcept C2778048844 @default.
• W2161853348 hasConcept C2778059366 @default.
• W2161853348 hasConcept C2778301690 @default.
• W2161853348 hasConcept C2778371730 @default.
• W2161853348 hasConcept C2779997623 @default.
• W2161853348 hasConcept C2780866276 @default.
• W2161853348 hasConcept C71924100 @default.
• W2161853348 hasConcept C86803240 @default.
• W2161853348 hasConcept C89423630 @default.
• W2161853348 hasConcept C98274493 @default.
• W2161853348 hasConceptScore W2161853348C114851261 @default.
• W2161853348 hasConceptScore W2161853348C126322002 @default.
• W2161853348 hasConceptScore W2161853348C203014093 @default.
• W2161853348 hasConceptScore W2161853348C2776120307 @default.
• W2161853348 hasConceptScore W2161853348C2776793103 @default.
• W2161853348 hasConceptScore W2161853348C2777035104 @default.
• W2161853348 hasConceptScore W2161853348C2777425658 @default.
• W2161853348 hasConceptScore W2161853348C2777616469 @default.

• next